Equitec Proprietary Markets, LLC / AIMT
Equitec Proprietary Markets, LLC’s Aimmune Therapeutics Inc Position
Does Equitec Proprietary Markets, LLC own Aimmune Therapeutics Inc (AIMT)? Not currently — the last reported position was 103.8K shares worth $4M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q3 2020
Shares
103.8K
% of Portfolio
+2.73%
Quarters Held
1
position exited
Position History AIMT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2020 | 103.8K | $4M | +2.73% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Equitec Proprietary Markets, LLC’s full portfolio or all institutional holders of AIMT.